SR

Santosh Rani

Active Director Director DIN 09752299
DIN 09752299 First appointment Sep 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Santosh Rani

Data last updated:

Santosh Rani is a Director at Jetson Pharma Private Limited (since 2022). The company operates in Trading. Jetson Pharma Private Limited reported revenue of ₹16.6 Lakh (FY 2025).

DIN 09752299
Primary Designation Director
Industry Trading
First Appointment 29 Sep 2022
Oldest Company Age 4 yrs
Largest company Jetson Pharma Private Limited · ₹16.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jetson Pharma Private Limited U51909PB2022PTC056989
Director29 Sep 20222022₹16.6 Lakh (FY 2025)Active

Board colleagues of Santosh Rani

NameDINCompanyDesignation
Jatinder Singh Thind09752298Jetson Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jetson Pharma Private Limited
Premium access

Shareholding and investment profile for Santosh Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Rani

Santosh Rani currently holds 1 directorship: Jetson Pharma Private Limited (Director, since 29 Sep 2022, revenue ₹16.6 Lakh (FY 2025)).

Santosh Rani was first appointed on 29 Sep 2022 as Director at Jetson Pharma Private Limited.

The current boards of Santosh Rani's companies include Jatinder Singh Thind (Jetson Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available